☰

Michael J. Dapp, Ph.D. - Publications

Affiliations: 
2012 Pharmacology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Microbiology Biology, Pharmacology, Virology Biology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Shahid A, MacLennan S, Jones BR, Sudderuddin H, Dang Z, Cobarrubias K, Duncan MC, Kinloch NN, Dapp MJ, Archin NM, Fischl MA, Ofotokun I, Adimora A, Gange S, Aouizerat B, et al. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time. Journal of Virology. e0165523. PMID 38214547 DOI: 10.1128/jvi.01655-23  0.532
2023 Shahid A, MacLennan S, Jones BR, Sudderuddin H, Dang Z, Cobarrubias K, Duncan MC, Kinloch NN, Dapp MJ, Archin NM, Fischl MA, Ofotokun I, Adimora A, Gange S, Aouizerat B, et al. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time. Research Square. PMID 37645749 DOI: 10.21203/rs.3.rs-3259040/v1  0.6
2022 Christian ML, Dapp MJ, Scharffenberger SC, Jones H, Song C, Frenkel LM, Krumm A, Mullins JI, Rawlings DJ. CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within Promotes Expansion of T Regulatory-like Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 35264460 DOI: 10.4049/jimmunol.2100491  0.573
2017 Dapp MJ, Kober KM, Chen L, Westfall DH, Wong K, Zhao H, Hall BM, Deng W, Sibley T, Ghorai S, Kim K, Chen N, McHugh S, Au L, Cohen M, et al. Patterns and rates of viral evolution in HIV-1 subtype B infected females and males. Plos One. 12: e0182443. PMID 29045410 DOI: 10.1371/Journal.Pone.0182443  0.569
2014 Dapp MJ, Bonnac L, Patterson SE, Mansky LM. Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63. PMID 24155391 DOI: 10.1128/Jvi.02444-13  0.793
2013 Rawson JM, Heineman RH, Beach LB, Martin JL, Schnettler EK, Dapp MJ, Patterson SE, Mansky LM. 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & Medicinal Chemistry. 21: 7222-8. PMID 24120088 DOI: 10.1016/J.Bmc.2013.08.023  0.771
2013 Dapp MJ, Patterson SE, Mansky LM. Back to the future: revisiting HIV-1 lethal mutagenesis. Trends in Microbiology. 21: 56-62. PMID 23195922 DOI: 10.1016/J.Tim.2012.10.006  0.776
2013 Dapp MJ, Heineman RH, Mansky LM. Interrelationship between HIV-1 fitness and mutation rate. Journal of Molecular Biology. 425: 41-53. PMID 23084856 DOI: 10.1016/J.Jmb.2012.10.009  0.753
2012 Dapp MJ, Holtz CM, Mansky LM. Concomitant lethal mutagenesis of human immunodeficiency virus type 1. Journal of Molecular Biology. 419: 158-70. PMID 22426127 DOI: 10.1016/J.Jmb.2012.03.003  0.463
2009 Dapp MJ, Clouser CL, Patterson S, Mansky LM. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. Journal of Virology. 83: 11950-8. PMID 19726509 DOI: 10.1128/Jvi.01406-09  0.778
Show low-probability matches.